Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

QRX PBP BLT NLS IT NZD Bitcoins Money Market Stores 
Benchmark SP 500  1,639   12.31  Index Moved Up 0.76% United States ...


Processing
Processing. Please wait...

Probiotec insider: Richard Kuo

       

Richard Kuo - Probiotec Insider Profile

Non-Executive Director

Mr. Richard David Kuo has served NonExecutive Independent Director of Probiotec Ltd since July 28, 2006. He holds MAICD. He holds Commerce and Law degrees with post graduate qualifications in applied finance and investment. Brings with him 26 years experience in law, investment banking and corporate strategy. Currently manages Pier Capital, a privately owned investment banking firm which provides corporate advice to a broad range of corporations and has experience in mergers and acquisitions, capital markets and strategic planning. He is NonExecutive Director of Glenorchy Art and Sculpture Park Limited.
  Director Since 2006      
61 3 9278 7555  http://www.probiotec.com.au

Other Appointments

PEOPLES COMM BANCRPPBPGermany Berlin
Director since 2006

Management Efficency

The company has return on total asset (ROA) of (0.05) % which means that it has lost $0.05 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (0.79) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 27.07 M in total debt with debt to equity ratio (D/E) of 0.43 which is about average as compared to similar companies. Probiotec Limited has Current Ratio of 0.66 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
    

Other Executives

Charles DipBus,ACA, CEO
Charles Stringer, CEO
AASA (Acc), Chairman
Maurice Ryn, Chairman
Jared BCom,BIT,CPA, CFO
Alan Hong, CFO
Graham Buckeridge, Director, CPA
Robin Tedder, Director
Robert Johnston, Director
Wesley Stringer, Director, CPA
B (Hons), Director
Dustin Stringer, Executive
Mark Chatfield, Executive
David Erasmus, Executive

Entity Summary

Probiotec Limited engages in the development, manufacture, and sale of pharmaceuticals, foods, and nutraceutical solutions in Australia and internationally. Probiotec Limited [PBP] is traded on Australian Securities Exchange in Australia. It is located in Laverton North, VIC and employs 18 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
PBP Australia Australian
Probiotec Limited
Benchmark S&P 500
Currency: AUD - Australian Dollar
Traded on Australian Securities Exchange
    
    
Chance of
Bankruptcy
Less
Than
48%
In The Next
Two Years
Probiotec Limited has less than 48.99 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

Probiotec price boundaries

    
June 07 2013
 0.30 
  
 0.27 
(0.03)  Macroaxis: -9.999999999999991 Down   10.00%  
Lowest period price (30 days)
May 21 2013
 0.33 
  
 0.35 
0.02  Macroaxis: 6.060606060606049 Up   6.06%  
Highest period price (30 days)
    

Promote Probiotec and Richard Kuo

Follow Probiotec with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Probiotec to your reader
 

Today Change

 thisGreen PBP PBP.AX agains markets  10.53 % Macroaxis: change 10.53 Moved Up  
 
 United States SP 500   0.76 % Macroaxis: 0.76 Moved Up  
 
 Australia All Or   0.22 % Macroaxis: 0.22 Moved Down  
 

Stock Performance

Shares Outstanding52.93 M


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium